Skip to main content
. 2018 Sep 10;19(15):1203–1216. doi: 10.2217/pgs-2018-0097

Figure 1. . Comparison of the highest levels of clinical evidence for the four selected pharmacogenetic case examples.

Figure 1. 

Clopidogrel for patients that received percutaneous coronary intervention; β-blockers for patients with inherited LQTS; thiopurines for patients with acute lymphoblastic leukemia; and epidermal growth factor inhibitors for patients with colon cancer.

LQTS: Long QT syndrome; RCT: Randomized controlled trial.